S. Lapenna
Molecular Biology · 2009
A researcher in the Science corpus: 1 paper; trusts 4 researchers and is trusted by 4 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 19 citations into it
- Oncology — 18 citations into it; #740 of 1,698 by trust here, #1,453 by citations
- Cell Biology — 16 citations into it; #925 of 2,073 by trust here, #1,656 by citations
Whom S. Lapenna trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts S. Lapenna overall
Papers from S. Lapenna's perspective
Ordered by how strongly the researchers S. Lapenna trusts endorse each paper. Same corpus, a different order for every researcher.
- Cyclin-dependent kinase 2 is essential for meiosis but not for mitotic cell division in mice (Nature Genetics)
- On the road to cancer: aneuploidy and the mitotic checkpoint (Nature Reviews. Cancer)
- ATM and related protein kinases: safeguarding genome integrity (Nature Reviews. Cancer)
- Microtubules as a target for anticancer drugs (Nature Reviews. Cancer)
- Mammalian cells cycle without the D-type cyclin-dependent kinases Cdk4 and Cdk6. (Cell)
- Cyclin-dependent kinase pathways as targets for cancer treatment. (Journal of Clinical Oncology)
- Cdk2 Knockout Mice Are Viable (Current Biology)
- Cell cycle, CDKs and cancer: a changing paradigm (Nature Reviews. Cancer)
- Identification and Characterization of a Novel and Specific Inhibitor of the Ataxia-Telangiectasia Mutated Kinase ATM (Cancer Research)
- Reaching for high-hanging fruit in drug discovery at protein–protein interfaces
Their papers
- Cell cycle kinases as therapeutic targets for cancer (2009) — 922 citations